Multinational pharmaceutical corporations are searching for means to broaden their capacity for drug development while decreasing costs. Pharmaceutical firms in India and China are increasingly forging partnerships with these corporations to gain revenue and to develop their own expertise. These...

We need to invest more in vaccines -- Promoting private investment in vaccine development -- A market not a prize -- Design choices -- $3 billion per disease -- Meeting industry requirements -- How sponsors can do it